Over time, GeneDx plans to expand into newborn screening, a potentially $10 billion marketthen eventually into adult screening to replace multi-gene panel and individual gene tests, a future market pegged at $16 billion, Katherine Stueland, GeneDxs president and CEO, told GEN Edge last month With tougher comps in 25 and a potential headwind to revenues emerging in HCT, it is harder to argue for multiple expansion from here, Peterson said
Hims and other telehealth companies first began selling compounded versions of Novos semaglutidea GLP-1 drug used for weight loss and diabetesduring a supply shortage several years ago, generally at a steep discount to the branded drugs
Mary Claire Haver Are They Worth It
In general, taking supplements on an empty stomach is recommended, as it allows them to be absorbed more quickly and efficiently
While GLP-1 refers to the natural hormone, Ozempic is a synthetic medication that replicates its effects to support weight loss
.png)
